Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31802236

Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Acta Neuropathol
Publication date
2020 Feb
First author
Liu APY

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Acta Neuropathol. 2020 Feb;139(2):273-275. doi: 10.1007/s00401-019-02115-8.
    note
    Source null
    related pmid
    31865440
    relationship
    Erratum in

Authors and identifiers

  1. name
    Liu APY
    type
    Author
  2. name
    Gudenas B
    type
    Author
  3. name
    Lin T
    type
    Author
  4. name
    Orr BA
    type
    Author
  5. name
    Klimo P Jr
    type
    Author
  6. name
    Kumar R
    type
    Author
  7. name
    Bouffet E
    type
    Author
  8. name
    Gururangan S
    type
    Author
  9. name
    Crawford JR
    type
    Author
  10. name
    Kellie SJ
    type
    Author
  11. name
    Chintagumpala M
    type
    Author
  12. name
    Fisher MJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Liu APY
    type
    Author
  2. name
    Gudenas B
    type
    Author
  3. name
    Lin T
    type
    Author
  4. name
    Orr BA
    type
    Author
  5. name
    Klimo P Jr
    type
    Author
  6. name
    Kumar R
    type
    Author
  7. name
    Bouffet E
    type
    Author
  8. name
    Gururangan S
    type
    Author
  9. name
    Crawford JR
    type
    Author
  10. name
    Kellie SJ
    type
    Author
  11. name
    Chintagumpala M
    type
    Author
  12. name
    Fisher MJ
    type
    Author
bibliography ids
  1. nci-bib-3c3a055f633a22ff6aa6f9bd
book metadata
content sha256
fb8f31552e7e0dbfe32b7f76799dddfb25a0b1856efbc9b135320713ecaa1157
document type
citation
dois
  1. 10.1007/s00401-019-02106-9
electronic publication date
display
2019 Dec 4
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31802236
immutable id
pubmed:31802236@fb8f31552e7e0dbfe32b7f76799dddfb25a0b1856efbc9b135320713ecaa1157
journal
abbreviation
Acta Neuropathol
issn electronic
1432-0533
issn print
0001-6322
issue
2
name
Acta neuropathologica
nlm unique id
0412041
pages
259-271
volume
139
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Acta Neuropathol. 2020 Feb;139(2):273-275. doi: 10.1007/s00401-019-02115-8.
    note
    Source null
    related pmid
    31865440
    relationship
    Erratum in
outcomes validated
false
pmid
31802236
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
9ef2446dd83ac309fe808a13ab0b651deec472b2923a3aef51a58c89e9bf87dc
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2020 Feb
precision
month
year
2020
publication types
  1. Clinical Trial, Phase II
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Multicenter Study
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31802236/
title
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.

Preserved source evidence · Not medical advice